MSH and MIF-I in animal models of tardive dyskinesia
- 1 July 1980
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 13 (1) , 37-40
- https://doi.org/10.1016/0091-3057(80)90117-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Choline chloride in animal models of tardive dyskinesiaLife Sciences, 1978
- Oral Choline Administration to Patients with Tardive DyskinesiaNew England Journal of Medicine, 1977
- Effect of apomorphine on schizophrenic symptomsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Choline in tardive dyskinesia and Huntington's diseaseLife Sciences, 1976
- Neuropharmacological tests with α-melanocyte stimulating hormoneLife Sciences, 1976
- α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areasPharmacology Biochemistry and Behavior, 1975
- Studies on the inhibition of oxotremorine induced tremor by a melanocyte‐stimulating hormone release‐inhibiting factor, thyrotropin releasing hormone and related peptidesFEBS Letters, 1974
- Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergicsPharmacology Biochemistry and Behavior, 1974
- Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in micePharmacology Biochemistry and Behavior, 1974
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971